First-in-human experience of sirolimus coated balloon for symptomatic intracranial artery stenosis

CONCLUSIONS: SCBs may be feasible and safe in selected patients with symptomatic ICAS, with high grade stenosis (70-99%). Further studies are warranted.PMID:38378241 | DOI:10.1136/jnis-2023-021177

Source: Atherosclerosis - February 20, 2024 Category: Cardiology Authors: Jichang Luo Renjie Yang Tao Wang Jian Chen Xia Lu Bin Yang Peng Gao Yabing Wang Yanfei Chen Adam A Dmytriw Jiamin Zheng Robert W Regenhardt Zheng Li Han Xu Yan Ma Jonathon Zhao Liqun Jiao Source Type: research